Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // November 2nd, 2011 // 6:50 am
Hello, everyone, and how are you today? Another unusual morning on the Pharmalot corporate campus, since the schoolhouses remain closed due to the ongoing lack of power around the greater pharmaceutical region. Nonetheless, we persevere, with help, of course, from a cup or two of stimulation. We hope you will join us. Meanwhile, there is much to do. So as we get busy, here are some tidbits from around the world. Hope your day goes well…
Boehringer Ties 50 Deaths To Pradaxa Bloodthinner (Reuters)
Ranbaxy Gets Approval For First Drug From An Indian Pharma (Economic Times)
Pfizer Confirms Interest In Over-The-Counter Lipitor (Bloomberg News)
India Plans Price Controls On 400 Essential Medicines (Pharma Times)
Pharma Is Faring Well In Bellwether Product Liability Cases (Reuters)
Bristol And Astra Diabetes Drug Seen As Innovative By Docs (Bloomberg News)
Genentech Settles Suit With Salami Maker Over Ammonia Leak (San Mateo County Times)
Prescription Painkiller Deaths Quadrupled In A Decade (Wall Street Journal)
Chinese Seize $30M In Counterfeit Drugs (China Daily)
Medicare Confirms Changes In Anemia Drug Use (Reuters)
EDITOR’S NOTE: Please check this post for updates throughout the morning
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Ammonia, Anemia, Aranesp, AstraZeneca, Bellwether Trials, Bloodthinner, Boehringer Ingelheim, Bristol Myers Squibb, China, Cleveland Clinic, Counterfeit Medicine, Dapagliflozin, Epogen, Genentech, India, Lipitor, Malaria, Medicare, Merck, Neurontin, OTC, Over The Counter, Painkillers, Pfizer, Pradaxa, Prescription Drug Prices, Ranbaxy Laboratories, Salami, Vioxx